Remdesivir associated with reduced mortality in hospitalized COVID-19 patients

Retrieved on: 2025-04-12 13:09:48

Tags for this article:

COVID-19 drug development

Nucleotides

Remdesivir

Cohort study

Electronic health record

Clinical trial

Click the tags to see associated articles and topics

Remdesivir associated with reduced mortality in hospitalized COVID-19 patients. View article details on hiswai:

Summary

The article discusses remdesivir (RDV) in COVID-19 treatment, using real-world data and electronic health records (EHRs) analyzed through machine learning (ML) and natural language processing (NLP). This aligns with the cohort study tag, illustrating an epidemiological approach to drug evaluation.

Article found on: bmcinfectdis.biomedcentral.com

View Original Article